Access News 6, Focus on Malaria, February 2002

HIV/AIDS INTELLECTUAL PROPERTY AND TRADE MALARIA TROPICAL & NEGLECTED DISEASES VACCINES

How much for an effective malaria treatment is the focus of this edition, as well as MSF in Burundi, Doha and a potential breakthrough, trapped in the ACCESS crisis, life with chagas and HIV and meningitis outbreaks.

Read, watch, share

Veena Panchal lives in Andheri East, a crowded suburb of Mumbai, along with her two children. She found out in 2002 that she was HIV positive, after the death of her husband from HIV/AIDS. Her two children are HIV negative.

Photograph by Subodh Pakhare

Press release

Press release |

10 February 2016

HIV/AIDS

India

Pharma company Viiv’s attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India

5 min

Stop Stock Outs (SSP) activists at the Stop Stock Outs (SSP) activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015.

Photograph by Stefan Heunis

Press release

Press release |

30 November 2015

Access News 6, Focus on Malaria, February 2002

Read, watch, share

Pharma company Viiv’s attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India

Antiretroviral drugs fail to consistently reach patients in countries most affected by HIV/AIDS

Stockouts testimonies

Living with HIV/Aids – The Need for Treatment Support

HIV: Despite better access to treatment, many AIDS patients in African hospitals still die

MSF reaction to latest UNAIDS report on global progress of scaling up life-saving HIV treatment

Yemen: antiretroviral treatment beneath the bombs

South Africa Should Override Patent on Key HIV Medicine After Widespread Stock Out Problem